| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chemokine activity | 1.77e-09 | 51 | 46 | 6 | GO:0008009 | |
| GeneOntologyMolecularFunction | CCR chemokine receptor binding | 3.17e-09 | 56 | 46 | 6 | GO:0048020 | |
| GeneOntologyMolecularFunction | CCR1 chemokine receptor binding | 1.20e-08 | 12 | 46 | 4 | GO:0031726 | |
| GeneOntologyMolecularFunction | CCR5 chemokine receptor binding | 1.74e-08 | 13 | 46 | 4 | GO:0031730 | |
| GeneOntologyMolecularFunction | chemokine receptor binding | 3.04e-08 | 81 | 46 | 6 | GO:0042379 | |
| GeneOntologyMolecularFunction | cytokine activity | 2.23e-05 | 250 | 46 | 6 | GO:0005125 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | 9.45e-05 | 324 | 46 | 6 | GO:0005126 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor binding | 1.17e-04 | 337 | 46 | 6 | GO:0001664 | |
| GeneOntologyMolecularFunction | chemoattractant activity | 2.61e-04 | 54 | 46 | 3 | GO:0042056 | |
| GeneOntologyMolecularFunction | cytidine deaminase activity | 3.98e-04 | 13 | 46 | 2 | GO:0004126 | |
| GeneOntologyMolecularFunction | protein kinase activity | 4.13e-04 | 600 | 46 | 7 | GO:0004672 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 6.91e-04 | 17 | 46 | 2 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 6.91e-04 | 17 | 46 | 2 | GO:0019198 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 1.11e-03 | 709 | 46 | 7 | GO:0016773 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 1.23e-03 | 938 | 46 | 8 | GO:0016772 | |
| GeneOntologyMolecularFunction | phospholipase activator activity | 1.27e-03 | 23 | 46 | 2 | GO:0016004 | |
| GeneOntologyMolecularFunction | receptor ligand activity | 1.52e-03 | 547 | 46 | 6 | GO:0048018 | |
| GeneOntologyMolecularFunction | signaling receptor activator activity | 1.62e-03 | 554 | 46 | 6 | GO:0030546 | |
| GeneOntologyMolecularFunction | kinase activity | 1.70e-03 | 764 | 46 | 7 | GO:0016301 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 1.72e-03 | 103 | 46 | 3 | GO:0004725 | |
| GeneOntologyMolecularFunction | lipase activator activity | 1.76e-03 | 27 | 46 | 2 | GO:0060229 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.54e-03 | 118 | 46 | 3 | GO:0003774 | |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | 2.76e-03 | 616 | 46 | 6 | GO:0030545 | |
| GeneOntologyMolecularFunction | deaminase activity | 2.78e-03 | 34 | 46 | 2 | GO:0019239 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 3.11e-03 | 36 | 46 | 2 | GO:0016814 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 3.46e-03 | 38 | 46 | 2 | GO:0000146 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 4.62e-03 | 146 | 46 | 3 | GO:0016810 | |
| GeneOntologyMolecularFunction | growth factor binding | 5.55e-03 | 156 | 46 | 3 | GO:0019838 | |
| GeneOntologyMolecularFunction | molecular function activator activity | 6.61e-03 | 1233 | 46 | 8 | GO:0140677 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 9.40e-03 | 189 | 46 | 3 | GO:0004721 | |
| GeneOntologyBiologicalProcess | eosinophil chemotaxis | 5.73e-11 | 30 | 47 | 6 | GO:0048245 | |
| GeneOntologyBiologicalProcess | eosinophil migration | 1.29e-10 | 34 | 47 | 6 | GO:0072677 | |
| GeneOntologyBiologicalProcess | antimicrobial humoral immune response mediated by antimicrobial peptide | 2.11e-08 | 134 | 47 | 7 | GO:0061844 | |
| GeneOntologyBiologicalProcess | chemokine-mediated signaling pathway | 8.50e-08 | 97 | 47 | 6 | GO:0070098 | |
| GeneOntologyBiologicalProcess | response to chemokine | 1.53e-07 | 107 | 47 | 6 | GO:1990868 | |
| GeneOntologyBiologicalProcess | cellular response to chemokine | 1.53e-07 | 107 | 47 | 6 | GO:1990869 | |
| GeneOntologyBiologicalProcess | antimicrobial humoral response | 2.01e-07 | 186 | 47 | 7 | GO:0019730 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | 8.07e-07 | 335 | 47 | 8 | GO:0043087 | |
| GeneOntologyBiologicalProcess | granulocyte chemotaxis | 9.59e-07 | 146 | 47 | 6 | GO:0071621 | |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | 1.25e-06 | 244 | 47 | 7 | GO:0043547 | |
| GeneOntologyBiologicalProcess | cytidine to uridine editing | 2.40e-06 | 12 | 47 | 3 | GO:0016554 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte migration | 2.83e-06 | 276 | 47 | 7 | GO:0097529 | |
| GeneOntologyBiologicalProcess | granulocyte migration | 3.24e-06 | 180 | 47 | 6 | GO:0097530 | |
| GeneOntologyBiologicalProcess | humoral immune response | 7.64e-06 | 321 | 47 | 7 | GO:0006959 | |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent cytokinesis | 1.02e-05 | 127 | 47 | 5 | GO:0061640 | |
| GeneOntologyBiologicalProcess | base conversion or substitution editing | 1.05e-05 | 19 | 47 | 3 | GO:0016553 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor production | 1.28e-05 | 133 | 47 | 5 | GO:0032760 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor superfamily cytokine production | 1.47e-05 | 137 | 47 | 5 | GO:1903557 | |
| GeneOntologyBiologicalProcess | positive regulation of cell migration | 2.20e-05 | 691 | 47 | 9 | GO:0030335 | |
| GeneOntologyBiologicalProcess | leukocyte chemotaxis | 3.06e-05 | 267 | 47 | 6 | GO:0030595 | |
| GeneOntologyBiologicalProcess | positive regulation of cell motility | 3.20e-05 | 725 | 47 | 9 | GO:2000147 | |
| GeneOntologyBiologicalProcess | positive regulation of locomotion | 3.84e-05 | 742 | 47 | 9 | GO:0040017 | |
| GeneOntologyBiologicalProcess | cytokine-mediated signaling pathway | 4.29e-05 | 577 | 47 | 8 | GO:0019221 | |
| GeneOntologyBiologicalProcess | cellular response to cytokine stimulus | 5.21e-05 | 967 | 47 | 10 | GO:0071345 | |
| GeneOntologyBiologicalProcess | leukocyte migration | 6.55e-05 | 449 | 47 | 7 | GO:0050900 | |
| GeneOntologyBiologicalProcess | regulation of secretion | 6.94e-05 | 801 | 47 | 9 | GO:0051046 | |
| GeneOntologyBiologicalProcess | cytokinesis | 9.86e-05 | 204 | 47 | 5 | GO:0000910 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell chemotaxis | 1.06e-04 | 7 | 47 | 2 | GO:2000503 | |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | 1.27e-04 | 499 | 47 | 7 | GO:0051345 | |
| GeneOntologyBiologicalProcess | response to cytokine | 1.34e-04 | 1083 | 47 | 10 | GO:0034097 | |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | 1.40e-04 | 878 | 47 | 9 | GO:0051336 | |
| GeneOntologyBiologicalProcess | maintenance of lens transparency | 1.41e-04 | 8 | 47 | 2 | GO:0036438 | |
| GeneOntologyBiologicalProcess | response to peptide | 1.52e-04 | 1100 | 47 | 10 | GO:1901652 | |
| GeneOntologyBiologicalProcess | cell chemotaxis | 1.67e-04 | 363 | 47 | 6 | GO:0060326 | |
| GeneOntologyBiologicalProcess | regulation of tumor necrosis factor production | 1.73e-04 | 230 | 47 | 5 | GO:0032680 | |
| GeneOntologyBiologicalProcess | regulation of tumor necrosis factor superfamily cytokine production | 1.95e-04 | 236 | 47 | 5 | GO:1903555 | |
| GeneOntologyBiologicalProcess | tumor necrosis factor production | 1.99e-04 | 237 | 47 | 5 | GO:0032640 | |
| GeneOntologyBiologicalProcess | tumor necrosis factor superfamily cytokine production | 2.23e-04 | 243 | 47 | 5 | GO:0071706 | |
| GeneOntologyBiologicalProcess | polar body extrusion after meiotic divisions | 2.26e-04 | 10 | 47 | 2 | GO:0040038 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell chemotaxis | 2.26e-04 | 10 | 47 | 2 | GO:2000501 | |
| GeneOntologyBiologicalProcess | natural killer cell chemotaxis | 3.31e-04 | 12 | 47 | 2 | GO:0035747 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | 3.31e-04 | 1211 | 47 | 10 | GO:0030334 | |
| GeneOntologyBiologicalProcess | secretion | OAS2 CCL3 A1CF ACVR2A ABR SEPTIN5 PTPRN SEPTIN4 PTPRN2 NTRK2 | 3.53e-04 | 1221 | 47 | 10 | GO:0046903 |
| GeneOntologyBiologicalProcess | astrocyte cell migration | 3.90e-04 | 13 | 47 | 2 | GO:0043615 | |
| GeneOntologyBiologicalProcess | meiotic cytokinesis | 3.90e-04 | 13 | 47 | 2 | GO:0033206 | |
| GeneOntologyBiologicalProcess | cytidine metabolic process | 4.54e-04 | 14 | 47 | 2 | GO:0046087 | |
| GeneOntologyBiologicalProcess | cytidine catabolic process | 4.54e-04 | 14 | 47 | 2 | GO:0006216 | |
| GeneOntologyBiologicalProcess | cytidine deamination | 4.54e-04 | 14 | 47 | 2 | GO:0009972 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | 5.13e-04 | 1280 | 47 | 10 | GO:2000145 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression via chromosomal CpG island demethylation | 5.24e-04 | 15 | 47 | 2 | GO:0044029 | |
| GeneOntologyBiologicalProcess | negative regulation by host of viral transcription | 5.24e-04 | 15 | 47 | 2 | GO:0043922 | |
| GeneOntologyBiologicalProcess | defense response to symbiont | OAS2 CCL3 CCL3L1 CCL4 CCL4L1 APOBEC3C CCL16 DMBT1 CCL24 MYO1C | 5.32e-04 | 1286 | 47 | 10 | GO:0140546 |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 5.69e-04 | 71 | 47 | 3 | GO:0043114 | |
| GeneOntologyBiologicalProcess | secretion by cell | 5.78e-04 | 1064 | 47 | 9 | GO:0032940 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside metabolic process | 5.98e-04 | 16 | 47 | 2 | GO:0046131 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside catabolic process | 5.98e-04 | 16 | 47 | 2 | GO:0046133 | |
| GeneOntologyBiologicalProcess | positive regulation of glial cell migration | 6.76e-04 | 17 | 47 | 2 | GO:1903977 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | 6.81e-04 | 1327 | 47 | 10 | GO:0040012 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside catabolic process | 7.60e-04 | 18 | 47 | 2 | GO:0046135 | |
| GeneOntologyBiologicalProcess | macrophage migration | 7.77e-04 | 79 | 47 | 3 | GO:1905517 | |
| GeneOntologyBiologicalProcess | glial cell migration | 8.06e-04 | 80 | 47 | 3 | GO:0008347 | |
| GeneOntologyBiologicalProcess | cell division | 9.47e-04 | 697 | 47 | 7 | GO:0051301 | |
| GeneOntologyBiologicalProcess | export from cell | 1.03e-03 | 1153 | 47 | 9 | GO:0140352 | |
| GeneOntologyBiologicalProcess | defense response to other organism | OAS2 CCL3 CCL3L1 CCL4 CCL4L1 APOBEC3C CCL16 DMBT1 CCL24 MYO1C | 1.07e-03 | 1407 | 47 | 10 | GO:0098542 |
| GeneOntologyBiologicalProcess | chemotaxis | 1.08e-03 | 517 | 47 | 6 | GO:0006935 | |
| GeneOntologyBiologicalProcess | taxis | 1.10e-03 | 519 | 47 | 6 | GO:0042330 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte chemotaxis | 1.14e-03 | 22 | 47 | 2 | GO:0140131 | |
| GeneOntologyBiologicalProcess | positive regulation of vascular permeability | 1.25e-03 | 23 | 47 | 2 | GO:0043117 | |
| GeneOntologyBiologicalProcess | ribonucleoside catabolic process | 1.60e-03 | 26 | 47 | 2 | GO:0042454 | |
| GeneOntologyBiologicalProcess | mRNA modification | 1.60e-03 | 26 | 47 | 2 | GO:0016556 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside metabolic process | 1.72e-03 | 27 | 47 | 2 | GO:0006213 | |
| GeneOntologyBiologicalProcess | regulation of glial cell migration | 1.98e-03 | 29 | 47 | 2 | GO:1903975 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | 2.06e-03 | 1028 | 47 | 8 | GO:0043085 | |
| GeneOntologyBiologicalProcess | inflammatory response | 2.26e-03 | 1043 | 47 | 8 | GO:0006954 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte chemotaxis | 2.27e-03 | 31 | 47 | 2 | GO:1901623 | |
| GeneOntologyBiologicalProcess | nucleoside catabolic process | 2.41e-03 | 32 | 47 | 2 | GO:0009164 | |
| GeneOntologyBiologicalProcess | mononuclear cell migration | 2.80e-03 | 258 | 47 | 4 | GO:0071674 | |
| GeneOntologyCellularComponent | septin complex | 4.06e-06 | 14 | 48 | 3 | GO:0031105 | |
| GeneOntologyCellularComponent | septin ring | 4.06e-06 | 14 | 48 | 3 | GO:0005940 | |
| GeneOntologyCellularComponent | septin cytoskeleton | 6.23e-06 | 16 | 48 | 3 | GO:0032156 | |
| GeneOntologyCellularComponent | secretory vesicle | KIF3C PSMD12 HMOX2 DMBT1 SEPTIN5 PTPRN SEPTIN4 PTPRN2 F5 PDIA3 VPS13B VPS35L | 1.79e-05 | 1246 | 48 | 12 | GO:0099503 |
| GeneOntologyCellularComponent | cell division site | 3.40e-05 | 80 | 48 | 4 | GO:0032153 | |
| GeneOntologyCellularComponent | distal axon | 5.67e-05 | 435 | 48 | 7 | GO:0150034 | |
| GeneOntologyCellularComponent | axon terminus | 1.18e-04 | 210 | 48 | 5 | GO:0043679 | |
| GeneOntologyCellularComponent | axon | 1.67e-04 | 891 | 48 | 9 | GO:0030424 | |
| GeneOntologyCellularComponent | neuron projection terminus | 1.91e-04 | 233 | 48 | 5 | GO:0044306 | |
| GeneOntologyCellularComponent | secretory granule | 4.36e-04 | 1014 | 48 | 9 | GO:0030141 | |
| GeneOntologyCellularComponent | synaptic vesicle | 6.08e-04 | 300 | 48 | 5 | GO:0008021 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | SPIRE2 HMOX2 DMBT1 MYO1C PTPRN PTPRN2 PDIA3 VPS13B NTRK2 VPS35L | 6.50e-04 | 1307 | 48 | 10 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | SPIRE2 HMOX2 DMBT1 MYO1C PTPRN PTPRN2 PDIA3 VPS13B NTRK2 VPS35L | 7.23e-04 | 1325 | 48 | 10 | GO:0012506 |
| GeneOntologyCellularComponent | exocytic vesicle | 8.14e-04 | 320 | 48 | 5 | GO:0070382 | |
| GeneOntologyCellularComponent | presynapse | 8.44e-04 | 886 | 48 | 8 | GO:0098793 | |
| GeneOntologyCellularComponent | secretory granule membrane | 9.21e-04 | 329 | 48 | 5 | GO:0030667 | |
| GeneOntologyCellularComponent | terminal bouton | 1.40e-03 | 96 | 48 | 3 | GO:0043195 | |
| GeneOntologyCellularComponent | cell cortex | 1.57e-03 | 371 | 48 | 5 | GO:0005938 | |
| GeneOntologyCellularComponent | neuronal cell body | 2.79e-03 | 835 | 48 | 7 | GO:0043025 | |
| Domain | SMALL_CYTOKINES_CC | 4.63e-07 | 26 | 46 | 4 | PS00472 | |
| Domain | Chemokine_CC_CS | 4.63e-07 | 26 | 46 | 4 | IPR000827 | |
| Domain | SCY | 3.37e-06 | 42 | 46 | 4 | SM00199 | |
| Domain | Septin | 3.93e-06 | 13 | 46 | 3 | PF00735 | |
| Domain | G_SEPTIN_dom | 3.93e-06 | 13 | 46 | 3 | IPR030379 | |
| Domain | G_SEPTIN | 3.93e-06 | 13 | 46 | 3 | PS51719 | |
| Domain | Chemokine_IL8-like_dom | 4.07e-06 | 44 | 46 | 4 | IPR001811 | |
| Domain | IL8 | 4.07e-06 | 44 | 46 | 4 | PF00048 | |
| Domain | Septin | 4.99e-06 | 14 | 46 | 3 | IPR016491 | |
| Domain | Receptor_IA-2 | 5.93e-06 | 2 | 46 | 2 | PF11548 | |
| Domain | Receptor_IA-2_dom | 5.93e-06 | 2 | 46 | 2 | IPR021613 | |
| Domain | RESP18 | 1.78e-05 | 3 | 46 | 2 | PF14948 | |
| Domain | RESP18_dom | 1.78e-05 | 3 | 46 | 2 | IPR029403 | |
| Domain | PTPc | 9.43e-05 | 36 | 46 | 3 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 1.20e-04 | 39 | 46 | 3 | PS50055 | |
| Domain | PTPase_domain | 1.40e-04 | 41 | 46 | 3 | IPR000242 | |
| Domain | Y_phosphatase | 1.40e-04 | 41 | 46 | 3 | PF00102 | |
| Domain | APOBEC_N | 3.86e-04 | 12 | 46 | 2 | PF08210 | |
| Domain | APOBEC_N | 3.86e-04 | 12 | 46 | 2 | IPR013158 | |
| Domain | PTPc_motif | 4.13e-04 | 59 | 46 | 3 | SM00404 | |
| Domain | Tyr_Pase_cat | 4.13e-04 | 59 | 46 | 3 | IPR003595 | |
| Domain | CYT_DCMP_DEAMINASES_2 | 6.11e-04 | 15 | 46 | 2 | PS51747 | |
| Domain | IQ | 7.11e-04 | 71 | 46 | 3 | PF00612 | |
| Domain | Tyr_Pase_AS | 7.71e-04 | 73 | 46 | 3 | IPR016130 | |
| Domain | Cytidine_deaminase-like | 7.88e-04 | 17 | 46 | 2 | IPR016193 | |
| Domain | CYT_DCMP_DEAMINASES_1 | 7.88e-04 | 17 | 46 | 2 | PS00903 | |
| Domain | CMP_dCMP_Zn-bd | 7.88e-04 | 17 | 46 | 2 | IPR002125 | |
| Domain | IQ | 1.04e-03 | 81 | 46 | 3 | SM00015 | |
| Domain | TYR_PHOSPHATASE_1 | 1.24e-03 | 86 | 46 | 3 | PS00383 | |
| Domain | TYR_PHOSPHATASE_2 | 1.28e-03 | 87 | 46 | 3 | PS50056 | |
| Domain | TYR_PHOSPHATASE_dom | 1.28e-03 | 87 | 46 | 3 | IPR000387 | |
| Domain | IQ_motif_EF-hand-BS | 1.41e-03 | 90 | 46 | 3 | IPR000048 | |
| Domain | - | 1.51e-03 | 92 | 46 | 3 | 3.90.190.10 | |
| Domain | IQ | 1.55e-03 | 93 | 46 | 3 | PS50096 | |
| Domain | Prot-tyrosine_phosphatase-like | 1.86e-03 | 99 | 46 | 3 | IPR029021 | |
| Domain | Myosin_head_motor_dom | 3.94e-03 | 38 | 46 | 2 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 3.94e-03 | 38 | 46 | 2 | PS51456 | |
| Domain | Myosin_head | 3.94e-03 | 38 | 46 | 2 | PF00063 | |
| Domain | MYSc | 3.94e-03 | 38 | 46 | 2 | SM00242 | |
| Domain | P-loop_NTPase | 4.42e-03 | 848 | 46 | 7 | IPR027417 | |
| Domain | CUB | 6.48e-03 | 49 | 46 | 2 | PF00431 | |
| Domain | CUB | 6.74e-03 | 50 | 46 | 2 | SM00042 | |
| Domain | - | 7.28e-03 | 52 | 46 | 2 | 2.60.120.290 | |
| Domain | CUB | 7.55e-03 | 53 | 46 | 2 | PS01180 | |
| Domain | CUB_dom | 8.69e-03 | 57 | 46 | 2 | IPR000859 | |
| Pathway | REACTOME_MRNA_EDITING_C_TO_U_CONVERSION | 1.27e-06 | 8 | 41 | 3 | M27683 | |
| Pathway | BIOCARTA_NKT_PATHWAY | 2.09e-06 | 32 | 41 | 4 | MM1492 | |
| Pathway | REACTOME_MRNA_EDITING | 2.70e-06 | 10 | 41 | 3 | M27709 | |
| Pathway | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | 2.33e-05 | 58 | 41 | 4 | MM14978 | |
| Pathway | WP_LUNG_FIBROSIS | 5.80e-05 | 73 | 41 | 4 | MM15827 | |
| Pathway | REACTOME_MRNA_EDITING_C_TO_U_CONVERSION | 1.72e-04 | 7 | 41 | 2 | MM15412 | |
| Pathway | WP_CHEMOKINE_SIGNALING_PATHWAY | 1.84e-04 | 184 | 41 | 5 | MM15943 | |
| Pathway | WP_COMPREHENSIVE_IL17A_SIGNALING | 2.85e-04 | 110 | 41 | 4 | MM16642 | |
| Pathway | REACTOME_MRNA_EDITING | 2.93e-04 | 9 | 41 | 2 | MM15445 | |
| Pathway | WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS | 4.92e-04 | 127 | 41 | 4 | M42533 | |
| Pathway | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | 5.99e-04 | 57 | 41 | 3 | M625 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNA12_13_RHO_SIGNALING_PATHWAY | 6.31e-04 | 13 | 41 | 2 | M47547 | |
| Pathway | KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION | 9.58e-04 | 264 | 41 | 5 | M9809 | |
| Pubmed | Genomic organization of the genes for human and mouse CC chemokine LEC. | 1.85e-12 | 11 | 48 | 5 | 10235110 | |
| Pubmed | 1.59e-11 | 5 | 48 | 4 | 17330138 | ||
| Pubmed | 1.11e-10 | 7 | 48 | 4 | 23431040 | ||
| Pubmed | 1.11e-10 | 7 | 48 | 4 | 12377948 | ||
| Pubmed | 1.11e-10 | 7 | 48 | 4 | 23648818 | ||
| Pubmed | 1.11e-10 | 7 | 48 | 4 | 1972563 | ||
| Pubmed | 1.11e-10 | 7 | 48 | 4 | 12960284 | ||
| Pubmed | 1.11e-10 | 7 | 48 | 4 | 12401480 | ||
| Pubmed | MIP-1alpha and MIP-1beta differentially mediate mucosal and systemic adaptive immunity. | 1.11e-10 | 7 | 48 | 4 | 12393512 | |
| Pubmed | 2.23e-10 | 8 | 48 | 4 | 11069716 | ||
| Pubmed | Regulatory T cells increase the avidity of primary CD8+ T cell responses and promote memory. | 2.23e-10 | 8 | 48 | 4 | 23112334 | |
| Pubmed | 2.23e-10 | 8 | 48 | 4 | 24370436 | ||
| Pubmed | 2.23e-10 | 8 | 48 | 4 | 9510207 | ||
| Pubmed | Basophils Promote Tumor Rejection via Chemotaxis and Infiltration of CD8+ T Cells. | 2.23e-10 | 8 | 48 | 4 | 27879269 | |
| Pubmed | A novel signaling pathway mediates the inhibition of CCL3/4 expression by prostaglandin E2. | 2.23e-10 | 8 | 48 | 4 | 15498767 | |
| Pubmed | 4.00e-10 | 9 | 48 | 4 | 33046212 | ||
| Pubmed | 4.00e-10 | 9 | 48 | 4 | 2521353 | ||
| Pubmed | 4.00e-10 | 9 | 48 | 4 | 17525185 | ||
| Pubmed | Reduced GRK2 level in T cells potentiates chemotaxis and signaling in response to CCL4. | 4.00e-10 | 9 | 48 | 4 | 14761932 | |
| Pubmed | 4.00e-10 | 9 | 48 | 4 | 7789623 | ||
| Pubmed | 4.00e-10 | 9 | 48 | 4 | 20046229 | ||
| Pubmed | 4.00e-10 | 9 | 48 | 4 | 12393595 | ||
| Pubmed | 6.66e-10 | 10 | 48 | 4 | 8496601 | ||
| Pubmed | CC family chemokines directly regulate myoblast responses to skeletal muscle injury. | 6.66e-10 | 10 | 48 | 4 | 18566004 | |
| Pubmed | 6.66e-10 | 10 | 48 | 4 | 11756344 | ||
| Pubmed | 1.05e-09 | 11 | 48 | 4 | 25895671 | ||
| Pubmed | 1.05e-09 | 11 | 48 | 4 | 15611273 | ||
| Pubmed | Molecular characterization of two murine eosinophil beta chemokine receptors. | 1.05e-09 | 11 | 48 | 4 | 7594543 | |
| Pubmed | 1.05e-09 | 11 | 48 | 4 | 37175837 | ||
| Pubmed | 1.05e-09 | 11 | 48 | 4 | 11972057 | ||
| Pubmed | 1.05e-09 | 11 | 48 | 4 | 35250464 | ||
| Pubmed | Mouse langerhans cells differentially express an activated T cell-attracting CC chemokine. | 1.05e-09 | 11 | 48 | 4 | 10594742 | |
| Pubmed | A YAC contig of the human CC chemokine genes clustered on chromosome 17q11.2. | 1.57e-09 | 12 | 48 | 4 | 8661057 | |
| Pubmed | 2.26e-09 | 13 | 48 | 4 | 8530103 | ||
| Pubmed | 2.26e-09 | 13 | 48 | 4 | 25847238 | ||
| Pubmed | Signaling lymphocyte activation molecule regulates development of colitis in mice. | 3.16e-09 | 14 | 48 | 4 | 22960654 | |
| Pubmed | Molecular cloning and functional characterization of a novel member of the C-C chemokine family. | 3.16e-09 | 14 | 48 | 4 | 7594550 | |
| Pubmed | 3.16e-09 | 14 | 48 | 4 | 25595646 | ||
| Pubmed | 4.31e-09 | 15 | 48 | 4 | 9139699 | ||
| Pubmed | 5.74e-09 | 16 | 48 | 4 | 1969921 | ||
| Pubmed | 6.62e-09 | 48 | 48 | 5 | 12080938 | ||
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 12070155 | ||
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 3058856 | ||
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 2521882 | ||
| Pubmed | 1.22e-08 | 19 | 48 | 4 | 10438970 | ||
| Pubmed | A high-resolution map of the chromosomal region surrounding the nude gene. | 1.22e-08 | 19 | 48 | 4 | 7601457 | |
| Pubmed | A 2-Mb YAC/BAC-based physical map of the ovum mutant (Om) locus region on mouse chromosome 11. | 1.52e-08 | 20 | 48 | 4 | 10995569 | |
| Pubmed | 1.52e-08 | 20 | 48 | 4 | 19853894 | ||
| Pubmed | 2.29e-08 | 22 | 48 | 4 | 9177770 | ||
| Pubmed | 2.46e-08 | 5 | 48 | 3 | 8525373 | ||
| Pubmed | 4.92e-08 | 6 | 48 | 3 | 20959807 | ||
| Pubmed | T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression. | 4.92e-08 | 6 | 48 | 3 | 26854929 | |
| Pubmed | 5.47e-08 | 27 | 48 | 4 | 12126650 | ||
| Pubmed | 5.47e-08 | 27 | 48 | 4 | 33887203 | ||
| Pubmed | 8.52e-08 | 30 | 48 | 4 | 28096401 | ||
| Pubmed | Thirty years on: HIV receptor gymnastics and the prevention of infection. | 8.60e-08 | 7 | 48 | 3 | 23692808 | |
| Pubmed | 9.77e-08 | 31 | 48 | 4 | 27022143 | ||
| Pubmed | 2.06e-07 | 9 | 48 | 3 | 24899193 | ||
| Pubmed | Superfluous role of mammalian septins 3 and 5 in neuronal development and synaptic transmission. | 2.06e-07 | 9 | 48 | 3 | 18809578 | |
| Pubmed | 2.53e-07 | 39 | 48 | 4 | 27318131 | ||
| Pubmed | Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. | 4.04e-07 | 11 | 48 | 3 | 21496894 | |
| Pubmed | 4.04e-07 | 11 | 48 | 3 | 12683974 | ||
| Pubmed | Cloning and characterization of a novel promiscuous human beta-chemokine receptor D6. | 6.99e-07 | 13 | 48 | 3 | 9405404 | |
| Pubmed | 1.36e-06 | 16 | 48 | 3 | 22575789 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 16269463 | ||
| Pubmed | HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. | 1.87e-06 | 2 | 48 | 2 | 10470075 | |
| Pubmed | The IA-2 gene family: homologs in Caenorhabditis elegans, Drosophila and zebrafish. | 1.87e-06 | 2 | 48 | 2 | 11206415 | |
| Pubmed | The dense core vesicle protein IA-2, but not IA-2β, is required for active avoidance learning. | 1.87e-06 | 2 | 48 | 2 | 24662847 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 28002786 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 8798755 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 19361477 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 23595248 | ||
| Pubmed | Cloning and expression of a lymphocyte activation gene (LAG-1). | 1.87e-06 | 2 | 48 | 2 | 2247088 | |
| Pubmed | The association of CCL3 and CCL4 polymorphisms with HCV clearance in Chinese Han population. | 1.87e-06 | 2 | 48 | 2 | 29705123 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 21030011 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 8024693 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 21732083 | ||
| Pubmed | Maladaptive myelination promotes generalized epilepsy progression. | 1.87e-06 | 2 | 48 | 2 | 35501379 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 18310453 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 11278300 | ||
| Pubmed | Beryllium-specific CD4+ T cells induced by chemokine neoantigens perpetuate inflammation. | 1.87e-06 | 2 | 48 | 2 | 33630763 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 12603824 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 25861885 | ||
| Pubmed | Dense core vesicle proteins IA-2 and IA-2beta: metabolic alterations in double knockout mice. | 1.87e-06 | 2 | 48 | 2 | 16306340 | |
| Pubmed | Possible role of the innate immunity in temporal lobe epilepsy. | 1.87e-06 | 2 | 48 | 2 | 18076643 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 36611058 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 15585099 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 29764502 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 9858807 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 19019914 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 19074730 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 19055602 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 23760235 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 33361824 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 29987448 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 1894635 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 12218153 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 17005260 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 20403075 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 16379602 | ||
| Interaction | CCR3 interactions | 2.01e-07 | 22 | 48 | 4 | int:CCR3 | |
| Interaction | AMZ2 interactions | 4.77e-07 | 27 | 48 | 4 | int:AMZ2 | |
| Interaction | CCR5 interactions | 5.55e-06 | 49 | 48 | 4 | int:CCR5 | |
| Interaction | SEPTIN3 interactions | 1.83e-05 | 66 | 48 | 4 | int:SEPTIN3 | |
| Interaction | NTN1 interactions | 3.17e-05 | 26 | 48 | 3 | int:NTN1 | |
| Interaction | SEPTIN12 interactions | 3.17e-05 | 26 | 48 | 3 | int:SEPTIN12 | |
| Interaction | SEPTIN14 interactions | 6.58e-05 | 33 | 48 | 3 | int:SEPTIN14 | |
| Interaction | SEPTIN4 interactions | 1.01e-04 | 38 | 48 | 3 | int:SEPTIN4 | |
| Cytoband | 17p13.3 | 1.11e-04 | 88 | 48 | 3 | 17p13.3 | |
| Cytoband | 17q12 | 1.57e-04 | 99 | 48 | 3 | 17q12 | |
| Cytoband | 17q24.2 | 4.57e-04 | 30 | 48 | 2 | 17q24.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | 5.21e-04 | 149 | 48 | 3 | chr17q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q24 | 4.77e-03 | 98 | 48 | 2 | chr17q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 5.71e-03 | 346 | 48 | 3 | chr17p13 | |
| GeneFamily | Chemokine ligands|Endogenous ligands | 2.58e-10 | 45 | 35 | 6 | 483 | |
| GeneFamily | Septins | 1.88e-06 | 13 | 35 | 3 | 732 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 8.63e-06 | 21 | 35 | 3 | 813 | |
| GeneFamily | Apolipoprotein B mRNA editing enzyme catalytic subunits | 2.37e-04 | 12 | 35 | 2 | 406 | |
| GeneFamily | Endogenous ligands | 1.10e-03 | 237 | 35 | 4 | 542 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.68e-03 | 161 | 35 | 3 | 593 | |
| Coexpression | GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 8.17e-07 | 176 | 48 | 6 | M9137 | |
| Coexpression | ZHANG_UTERUS_C10_STROMAL2_RETNLG_HIGH_CELL | 2.93e-06 | 54 | 48 | 4 | MM16616 | |
| Coexpression | SAUL_SEN_MAYO | 3.06e-06 | 123 | 48 | 5 | MM16098 | |
| Coexpression | GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN | 2.56e-05 | 93 | 48 | 4 | MM1149 | |
| Coexpression | LI_INDUCED_T_TO_NATURAL_KILLER_UP | 3.71e-05 | 343 | 48 | 6 | MM1059 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_22 | 4.17e-05 | 211 | 48 | 5 | MM17089 | |
| Coexpression | ZHANG_UTERUS_C9_DENDRITIC_CELL | 5.70e-05 | 114 | 48 | 4 | MM16615 | |
| Coexpression | SAUL_SEN_MAYO | 7.90e-05 | 124 | 48 | 4 | M45803 | |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_2 | 1.17e-04 | 9 | 48 | 2 | M39042 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_DN | 1.26e-04 | 267 | 48 | 5 | MM1091 | |
| ToppCell | Control-Myeloid-TRAM2|Control / Condition, Lineage and Cell class | 6.28e-08 | 194 | 48 | 6 | d951dd1274d3ff1ac30671ec4153a4a8bc97b53f | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.13e-07 | 164 | 48 | 5 | be49af6335f2505065cde2cb9800e4a5516811b1 | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-06 | 171 | 48 | 5 | 41932c9e70829ee3d55ca5fdb74d290fc8229416 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_1|Classical_Monocyte / Disease condition and Cell class | 1.28e-06 | 20 | 48 | 3 | f245d0c009d45a3bd18cd970d82f10da2936c9f5 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.53e-06 | 78 | 48 | 4 | d5e2e2e04e380b265b2530e93cba6f98ad329e4f | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.74e-06 | 187 | 48 | 5 | 59d28f4ee1d463ae20abb8d7e7399b504d80698a | |
| ToppCell | Control-Myeloid-MoAM5|Control / Disease group,lineage and cell class （2021.01.30） | 1.74e-06 | 187 | 48 | 5 | 8769341be67382cea2a590d962f4def7c39de883 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.74e-06 | 187 | 48 | 5 | 25adf648c05c21534b4913254e73d43fc5f64e06 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.74e-06 | 187 | 48 | 5 | 3b0cfa9e5ea5e7d6dda689c328b9b5110b43ee1d | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.74e-06 | 187 | 48 | 5 | 0d589de12108230ced5b60229564f4a181e2f172 | |
| ToppCell | Control-Myeloid-TRAM2|Myeloid / Condition, Lineage and Cell class | 1.98e-06 | 192 | 48 | 5 | 571fd71dad361a8b6c1bf9ad7184a89b3fbec667 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.30e-06 | 198 | 48 | 5 | 0e918e9db9b884f5328d438e90efe065e27266ee | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.30e-06 | 198 | 48 | 5 | ce92d5fbc2eac27fb246b044fb1914ab92506275 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.30e-06 | 198 | 48 | 5 | fed823d6e684d113bcc9ff3cd1803bb001aa02fa | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.30e-06 | 198 | 48 | 5 | 1ef3a6bd681c223eed58300348adfef89df5563c | |
| ToppCell | Severe_COVID-19|World / Disease group,lineage and cell class （2021.01.30） | 2.30e-06 | 198 | 48 | 5 | 09fd456077bb3a657ad3b10c6cfe799b7266456a | |
| ToppCell | BAL-Severe|BAL / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.30e-06 | 198 | 48 | 5 | 454aee3f4fe6d0beeccc55200b4495f4f9b44feb | |
| ToppCell | BAL-Severe|BAL / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.30e-06 | 198 | 48 | 5 | 687f69c16343227854c882b4a0f3930ce534a3d2 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-NK_activated|COVID-19_Severe / Disease group, lineage and cell class | 2.36e-06 | 199 | 48 | 5 | edf5f80b4c299e6bf462675f2cd3329d86c923d8 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_1|COVID-19_Convalescent / Disease condition and Cell class | 2.58e-06 | 25 | 48 | 3 | 00e8c78c4fcc961eb37ea5838f4203ae32cf7faa | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-05 | 142 | 48 | 4 | be63c48794a227ea55978524c0f5935342fc455e | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.65e-05 | 160 | 48 | 4 | 7f1b58641ba149d20420fafad34ba78a65a2c701 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.79e-05 | 162 | 48 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.79e-05 | 162 | 48 | 4 | 228e33678c7f963b3032a218333f206e5fff1292 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 163 | 48 | 4 | 5fc836444bc156c8248abee001b0ecbe43f980c9 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 163 | 48 | 4 | 2e1c1193c04620cc187b1567dfba025beef1e4e1 | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-05 | 164 | 48 | 4 | 7a51365bad2910c130bd952805f7a1bef51be481 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.99e-05 | 165 | 48 | 4 | cece16b03282d27fb49102eb9c104a2024efd28c | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 165 | 48 | 4 | e24621c8d4dbafb407033d832fe9337f13feae34 | |
| ToppCell | facs-Heart-LA-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 166 | 48 | 4 | 19ec59f0a43d4eb5b4cc7bcd6480ada7f469054b | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.14e-05 | 167 | 48 | 4 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | droplet-Spleen-nan-21m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-05 | 167 | 48 | 4 | 92ddabbe55315856d8ea6f8db1560b6d97636bac | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-05 | 167 | 48 | 4 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-05 | 169 | 48 | 4 | 18ba8fc2ba8838484d3b223428cd41568e2ccb10 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-05 | 169 | 48 | 4 | 47a63afd80cb7ba2258ba57d3084d8b2a7bc4e8d | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.29e-05 | 169 | 48 | 4 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.52e-05 | 172 | 48 | 4 | f673a2e697b46e7cfa4186cb3fb2b98e3c83703e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.52e-05 | 172 | 48 | 4 | e3a8891694343b6b01e80a200ae338d24797e417 | |
| ToppCell | 18-Airway-Immune-Hematopoietic,_Natural_Killer_Cell|Airway / Age, Tissue, Lineage and Cell class | 3.60e-05 | 173 | 48 | 4 | 054cb468a2a10a96aa1d971618993f6777569e14 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 3.60e-05 | 173 | 48 | 4 | 1e8a43ff32eab95857c794e0bf4f0b0dba155b4a | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.68e-05 | 174 | 48 | 4 | 9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.76e-05 | 175 | 48 | 4 | 8362a46f5804333baa84cd56d450bc147f372a7e | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.76e-05 | 175 | 48 | 4 | 8b4c62e608f0ec84e563bbf0ebffe3ed44085298 | |
| ToppCell | 21-Trachea-Immune-Hematopoietic,_Natural_Killer_Cell|Trachea / Age, Tissue, Lineage and Cell class | 4.02e-05 | 178 | 48 | 4 | d2e1f6b7933b7da2682393e5ff5e03cdd8f64761 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.11e-05 | 179 | 48 | 4 | 898425fa81526a2e00fca7a25085229ff1f31069 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.11e-05 | 179 | 48 | 4 | 2fca4117c58824562ec80c7713fe15689a28efb3 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.20e-05 | 180 | 48 | 4 | f3d8329b7e754c1ed89b0f39b8cd9e2ae22f6725 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.20e-05 | 180 | 48 | 4 | dcec59d66995f701d816eaeea3ed1439a2f71b73 | |
| ToppCell | Control-Myeloid-MoAM2|Control / Disease group,lineage and cell class （2021.01.30） | 4.20e-05 | 180 | 48 | 4 | 38892483a6a5388765aec87f0119c0b9bb5c7cbd | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 4.39e-05 | 182 | 48 | 4 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.58e-05 | 184 | 48 | 4 | e5756afa3181186f9b65552b8df5359ef4024bee | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 184 | 48 | 4 | e33bb572af9dfd11127105f1ac99bc958a7cafbb | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.67e-05 | 185 | 48 | 4 | f30fb9d75cdb757b206312992aaf7485bc900f96 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.67e-05 | 185 | 48 | 4 | d42f6722a6771752cd744146a09e2ead9b7252bc | |
| ToppCell | droplet-Bladder-Unstain-18m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-05 | 186 | 48 | 4 | e3a14f3ccadbf3211822c67b8956ee01f563307a | |
| ToppCell | Control-Lymphoid-CD8_T_cells|Lymphoid / Condition, Lineage and Cell class | 4.77e-05 | 186 | 48 | 4 | a8a4c0f4058f5bbc435dd2dd41d55383173a1358 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.87e-05 | 187 | 48 | 4 | bde6b90955423eab6a91a0abe75d0a95a1f5330a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.87e-05 | 187 | 48 | 4 | d17352f769c3c66601b65d060626eecff41b0482 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Undetermined|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 4.98e-05 | 188 | 48 | 4 | 8231e635706a296db6b6da1029a33bbc1b52478e | |
| ToppCell | Control-Myeloid-MoAM1|Control / Disease group,lineage and cell class （2021.01.30） | 5.08e-05 | 189 | 48 | 4 | 55d5c2fb9e6ab556d42c83a1e985ee66e4cf9dba | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.08e-05 | 189 | 48 | 4 | 440c422369de1c49112d18cf8c506a2a3a81f6ba | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.08e-05 | 189 | 48 | 4 | ebb5e069fdca7cf8ffac16a57572e92d2593c86a | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.08e-05 | 189 | 48 | 4 | a438c64a893d43f781ede42e1c7b615b74dc76ef | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.08e-05 | 189 | 48 | 4 | a59e4eaff430a443f9fa7edabe64e66a15b6bffb | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.18e-05 | 190 | 48 | 4 | 5c8aa310886c64ee5dce4ba46a3dd178da549529 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.18e-05 | 190 | 48 | 4 | 4b4fe93061c87605dddf5bec94fa07c749c722aa | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.18e-05 | 190 | 48 | 4 | e0b363f772817cfc6ab425430805c1cddcba23f0 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.29e-05 | 191 | 48 | 4 | 09dfad8e1fcaaf94775134796b99e4e3fbb9bf40 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 5.40e-05 | 192 | 48 | 4 | 5841378789d8267f94071df060debc9171700784 | |
| ToppCell | 18-Distal-Immune-Hematopoietic,_Macrophage|Distal / Age, Tissue, Lineage and Cell class | 5.40e-05 | 192 | 48 | 4 | e54577183b09599a3b2bdd532a18ea8f4a6e3524 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.40e-05 | 192 | 48 | 4 | 6ac7ba0ef7d1b4f85dc12fa3f0ebaddc57f214a5 | |
| ToppCell | 18-Distal-Immune-Hematopoietic,_Natural_Killer_Cell|Distal / Age, Tissue, Lineage and Cell class | 5.40e-05 | 192 | 48 | 4 | dd47d47d0a7219771b275c4cf5f2b768424216c8 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.51e-05 | 193 | 48 | 4 | 837c61408462c519912ecf3b83fdc72cd85fe88f | |
| ToppCell | Control-Myeloid-MoAM3|Control / Disease group,lineage and cell class （2021.01.30） | 5.51e-05 | 193 | 48 | 4 | 97d2f12be43fc26efa84ac4c6119132928a123de | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.51e-05 | 193 | 48 | 4 | d81840e1322507552b7726bf7828309375162324 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.51e-05 | 193 | 48 | 4 | b044fca95f519ff2ceb378afe40a95911931a29e | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 5.51e-05 | 193 | 48 | 4 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.51e-05 | 193 | 48 | 4 | e4ca3a3c2704cdc52e6ac3f25f14debf74226c29 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.51e-05 | 193 | 48 | 4 | 2684fa361baaa9dc7a18a39ed11c0759e78e4418 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.51e-05 | 193 | 48 | 4 | e54f8b6381b5a96758cff41ab12d6f60cfca29a9 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.62e-05 | 194 | 48 | 4 | ef30baa19b7aa97b61dea916fc2e0f5cf49848d6 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.62e-05 | 194 | 48 | 4 | 64535db0420e53e4d777d2333b5051e63e8a3373 | |
| ToppCell | Control-Myeloid-MoAM5,_CCL3L1|Myeloid / Condition, Lineage and Cell class | 5.62e-05 | 194 | 48 | 4 | 96400477d130b2403ed81c229e4e4182cc2cdc14 | |
| ToppCell | BAL-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.62e-05 | 194 | 48 | 4 | a4523adbbd25c314809eed3414d66a5b323446e5 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-05 | 194 | 48 | 4 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | 18-Airway-Immune-Hematopoietic,_Macrophage|Airway / Age, Tissue, Lineage and Cell class | 5.62e-05 | 194 | 48 | 4 | 9671fed8cd45ea8c7a411239aa5012c2a1edf264 | |
| ToppCell | Control-Myeloid-MoAM5,_CCL3L1|Control / Condition, Lineage and Cell class | 5.62e-05 | 194 | 48 | 4 | a1dd264822de83a0ffaf89ca4707c6a76809359e | |
| ToppCell | BAL-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.62e-05 | 194 | 48 | 4 | 125bf2909cf89133693bc7b865ca08955cf67a2e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.62e-05 | 194 | 48 | 4 | 52e09b14159b609af00264a8f38accf37ba8f464 | |
| ToppCell | IIF-Lymphocyte-T_NK-NK|IIF / Disease, Lineage and Cell Type | 5.73e-05 | 195 | 48 | 4 | 464ce05cb52f78aee22d3baa6641b37bd53aae16 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.85e-05 | 196 | 48 | 4 | 4bdc304c0c9d8bebe1a6a8a27e44acd1e8113725 | |
| ToppCell | CV-Severe|CV / Virus stimulation, Condition and Cluster | 5.85e-05 | 196 | 48 | 4 | d0ddeaaa9ad0576e312a49bd3e68d12addccad3c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.97e-05 | 197 | 48 | 4 | 1ca06d6d288cb58a6e8062ebc01831e58ee5be4b | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 5.97e-05 | 197 | 48 | 4 | 2bf540fa228687a71f595a807e4a2af20588a82c | |
| ToppCell | 343B-Lymphocytic-NK_cells|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.97e-05 | 197 | 48 | 4 | e1009fa54d365a7f4345fef836da6076b5c1c3d0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.08e-05 | 198 | 48 | 4 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-gd_T|URO / Disease, condition lineage and cell class | 6.08e-05 | 198 | 48 | 4 | cb584f7754ef4e6d9ec7155022852f2d2676ab4f | |
| ToppCell | mild-Lymphocytic-NK_cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.08e-05 | 198 | 48 | 4 | dce3c008757786aa6bd4a869456b76b4cbbb1d5b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.08e-05 | 198 | 48 | 4 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | T_cells-GZMK+GZMB+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.08e-05 | 198 | 48 | 4 | 085ba270f9defbf5ef45108c6d870e1d7c428479 | |
| Drug | BX471 | 9.74e-07 | 36 | 48 | 4 | CID000512282 | |
| Drug | Co-protoporphyrin IX | 4.92e-06 | 118 | 48 | 5 | CID000004972 | |
| Drug | Betamethasone | 3.09e-05 | 29 | 48 | 3 | ctd:D001623 | |
| Drug | 1k1n | 4.00e-05 | 182 | 48 | 5 | CID000177837 | |
| Drug | S-propyl-l-cysteine | 4.33e-05 | 5 | 48 | 2 | CID000101975 | |
| Drug | roflumilast N-oxide | 4.33e-05 | 5 | 48 | 2 | ctd:C517734 | |
| Drug | fipexide | 4.33e-05 | 5 | 48 | 2 | CID000003351 | |
| Drug | NSC-163039 | 4.91e-05 | 190 | 48 | 5 | CID000005064 | |
| Drug | Albendazole [54965-21-8]; Up 200; 15uM; HL60; HG-U133A | 5.29e-05 | 193 | 48 | 5 | 1547_UP | |
| Drug | Retrorsine [480-54-6]; Down 200; 11.4uM; HL60; HT_HG-U133A | 5.29e-05 | 193 | 48 | 5 | 2129_DN | |
| Drug | Haloperidol [52-86-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 5.29e-05 | 193 | 48 | 5 | 5273_UP | |
| Drug | Lysergol [602-85-7]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 5.70e-05 | 196 | 48 | 5 | 3261_UP | |
| Drug | Sisomicin sulfate [53179-09-2]; Down 200; 2.8uM; HL60; HT_HG-U133A | 5.70e-05 | 196 | 48 | 5 | 2493_DN | |
| Drug | Ondansetron Hydrochloride [103639-04-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 5.98e-05 | 198 | 48 | 5 | 3575_UP | |
| Drug | CGX 0596987; Down 200; 20uM; MCF7; HT_HG-U133A | 6.12e-05 | 199 | 48 | 5 | 6364_DN | |
| Drug | enterotoxin F, Staphylococcal | 9.08e-05 | 7 | 48 | 2 | ctd:C030107 | |
| Drug | methylbenzethonium chloride | 9.08e-05 | 7 | 48 | 2 | ctd:C005106 | |
| Drug | Picibanil | 9.08e-05 | 7 | 48 | 2 | ctd:D010844 | |
| Drug | coralyne | 9.08e-05 | 7 | 48 | 2 | ctd:C000666 | |
| Drug | Trichloro | 9.08e-05 | 7 | 48 | 2 | CID000522369 | |
| Drug | meclocycline | 9.08e-05 | 7 | 48 | 2 | ctd:C100122 | |
| Drug | Propidium | 1.21e-04 | 8 | 48 | 2 | ctd:D011419 | |
| Drug | alexidine | 1.21e-04 | 8 | 48 | 2 | ctd:C001570 | |
| Drug | C0761 | 1.21e-04 | 8 | 48 | 2 | CID006321196 | |
| Drug | N-cyclopropylammelide | 1.21e-04 | 8 | 48 | 2 | CID000592814 | |
| Drug | irbesartan | 1.49e-04 | 127 | 48 | 4 | CID000003749 | |
| Drug | Fludrocortisone | 1.55e-04 | 9 | 48 | 2 | ctd:D005438 | |
| Drug | iron-EDTA | 1.55e-04 | 9 | 48 | 2 | CID000088882 | |
| Drug | Methionine Sulfoximine | 1.55e-04 | 9 | 48 | 2 | ctd:D008717 | |
| Drug | tigecycline | 1.55e-04 | 9 | 48 | 2 | ctd:C119092 | |
| Drug | CAS 80474-14-2 | 1.67e-04 | 131 | 48 | 4 | CID000003399 | |
| Drug | alclometasone dipropionate | 1.94e-04 | 10 | 48 | 2 | ctd:C021137 | |
| Drug | Benzethonium | 1.94e-04 | 10 | 48 | 2 | ctd:D001558 | |
| Drug | periplocin | 1.94e-04 | 10 | 48 | 2 | CID000025735 | |
| Drug | cobalt sulfate | 1.94e-04 | 10 | 48 | 2 | CID000024965 | |
| Disease | status epilepticus (biomarker_via_orthology) | 4.43e-07 | 100 | 45 | 5 | DOID:1824 (biomarker_via_orthology) | |
| Disease | Chagas disease (biomarker_via_orthology) | 3.40e-05 | 6 | 45 | 2 | DOID:12140 (biomarker_via_orthology) | |
| Disease | C-C motif chemokine 3-like 1 measurement | 6.33e-05 | 8 | 45 | 2 | EFO_0008052 | |
| Disease | crescentic glomerulonephritis (biomarker_via_orthology) | 6.33e-05 | 8 | 45 | 2 | DOID:13139 (biomarker_via_orthology) | |
| Disease | anterior uveitis (biomarker_via_orthology) | 8.13e-05 | 9 | 45 | 2 | DOID:1407 (biomarker_via_orthology) | |
| Disease | post-traumatic stress disorder (biomarker_via_orthology) | 8.13e-05 | 9 | 45 | 2 | DOID:2055 (biomarker_via_orthology) | |
| Disease | Brain Ischemia | 1.07e-04 | 60 | 45 | 3 | C0007786 | |
| Disease | Cerebral Ischemia | 1.07e-04 | 60 | 45 | 3 | C0917798 | |
| Disease | Allergic Reaction | 1.23e-04 | 63 | 45 | 3 | C1527304 | |
| Disease | nephritis (biomarker_via_orthology) | 1.24e-04 | 11 | 45 | 2 | DOID:10952 (biomarker_via_orthology) | |
| Disease | Hypersensitivity | 1.29e-04 | 64 | 45 | 3 | C0020517 | |
| Disease | Petit mal status | 1.48e-04 | 67 | 45 | 3 | C0270823 | |
| Disease | Grand Mal Status Epilepticus | 1.48e-04 | 67 | 45 | 3 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 1.48e-04 | 67 | 45 | 3 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 1.48e-04 | 67 | 45 | 3 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 1.48e-04 | 67 | 45 | 3 | C0751523 | |
| Disease | Complex Partial Status Epilepticus | 1.48e-04 | 67 | 45 | 3 | C0393734 | |
| Disease | renal fibrosis (biomarker_via_orthology) | 1.49e-04 | 12 | 45 | 2 | DOID:0050855 (biomarker_via_orthology) | |
| Disease | Status Epilepticus | 1.55e-04 | 68 | 45 | 3 | C0038220 | |
| Disease | beta-2-microglobulin measurement | 2.05e-04 | 14 | 45 | 2 | EFO_0020180 | |
| Disease | – | 2.69e-04 | 16 | 45 | 2 | 609423 | |
| Disease | Susceptibility to HIV infection | 2.69e-04 | 16 | 45 | 2 | cv:C1836230 | |
| Disease | uric acid measurement | 3.13e-04 | 610 | 45 | 6 | EFO_0004761 | |
| Disease | Lung Injury | 4.69e-04 | 21 | 45 | 2 | C0273115 | |
| Disease | Chronic Lung Injury | 4.69e-04 | 21 | 45 | 2 | C2350344 | |
| Disease | diabetes mellitus (implicated_via_orthology) | 7.22e-04 | 26 | 45 | 2 | DOID:9351 (implicated_via_orthology) | |
| Disease | anti-basement membrane glomerulonephritis (biomarker_via_orthology) | 9.63e-04 | 30 | 45 | 2 | DOID:4780 (biomarker_via_orthology) | |
| Disease | Bright Disease | 1.03e-03 | 31 | 45 | 2 | C1704377 | |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 1.03e-03 | 31 | 45 | 2 | DOID:3328 (biomarker_via_orthology) | |
| Disease | Glomerulonephritis | 1.03e-03 | 31 | 45 | 2 | C0017658 | |
| Disease | gestational age | 1.23e-03 | 138 | 45 | 3 | EFO_0005112 | |
| Disease | ovarian carcinoma | 1.44e-03 | 321 | 45 | 4 | EFO_0001075 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KEFYDNLCPKVQQWD | 151 | Q12979 | |
| QQFCGDPKQEWVQRY | 71 | O00175 | |
| CTNPNDDWVQEYIKD | 76 | O15467 | |
| IQWVEENFPENKEYL | 31 | O43683 | |
| LEEICQKNNWGQPVY | 451 | Q9NQ94 | |
| FPIQDKQSWQNEYEV | 221 | P27037 | |
| CWENFVYNDNEPFKP | 156 | Q9NRW3 | |
| QEFWNFCEVPVEAVD | 116 | Q9NW81 | |
| PQDFEYVWQNFVEQE | 181 | Q9Y235 | |
| EFVIPSVYWVEDQNK | 296 | Q9H000 | |
| EKEWEALCAYQAEPN | 746 | Q92932 | |
| PDKVFAEKWNENVQY | 241 | O43929 | |
| KEWQALCAYQAEPNT | 711 | Q16849 | |
| EVPWKYVINTCGQDF | 181 | Q8N0V5 | |
| PKQYCNQILWFDSTD | 141 | Q9H9K5 | |
| KQVCADPSESWVQEY | 71 | P13236 | |
| FLDCEEEQWKFQPLV | 651 | O14782 | |
| QDDEFVVNYCLKAQW | 466 | P50748 | |
| YDTPCIQAESEKWQQ | 251 | O00232 | |
| FFGENWEEQVQCPKA | 116 | P30519 | |
| WEEQVQCPKAAQKYV | 121 | P30519 | |
| NEKVYENEDQLLWCP | 196 | Q7Z3K6 | |
| EFVYWPNKDEPINCE | 2131 | P23471 | |
| CIFWKVNYNFEDETV | 606 | P29728 | |
| KQVCADPSESWVQEY | 71 | Q8NHW4 | |
| FEEGQAQWDCVNPKY | 331 | Q9UBL6 | |
| EKNYEWSFIQCPACQ | 1001 | Q5VV63 | |
| QVCADPSEEWVQKYV | 71 | P10147 | |
| YPNNAKCVWEIEVNS | 1786 | Q9UGM3 | |
| GNYPNNAKCVWDIEV | 2026 | Q9UGM3 | |
| PEYFWCQFADTEKLQ | 1531 | O60522 | |
| VNNTECWKPVAEYID | 216 | O43236 | |
| CWKPVAEYIDQQFEQ | 221 | O43236 | |
| VNNTECWKPITDYVD | 116 | Q99719 | |
| CWKPITDYVDQQFEQ | 121 | Q99719 | |
| SWYLEDNINKFCENP | 556 | P12259 | |
| NNENKDVLIEFYAPW | 391 | P30101 | |
| WEVNPLYCDTVKQIY | 371 | Q96MK3 | |
| KPWFLTNEVEECENY | 106 | Q9BQG2 | |
| RQVCADPSEEWVQKY | 71 | P16619 | |
| PQELWKNICQEAKNY | 891 | O75153 | |
| KQPWYQLSNNEVIEC | 751 | Q16620 | |
| LKNPQDYINCAEVWV | 496 | Q7Z3J2 | |
| DQINNENCWEPIEKY | 131 | Q9UH03 | |
| ENCWEPIEKYINEQY | 136 | Q9UH03 | |
| YEQPLNEEQAWAVCF | 31 | Q8WWL2 | |
| CVVWPINFNESYLEN | 281 | Q9UQD0 | |
| QQVEKVFGLEEYWCQ | 111 | Q6ZN44 | |
| VPCSLEYWDELQKVF | 2376 | Q7Z7G8 | |
| KPEVLDWQDQVFQFC | 601 | Q14202 | |
| IAWEPVQYFNNKIIC | 466 | O00159 | |
| FWMAPEVIACEQQYD | 196 | Q8WXR4 | |
| YFERPLQWKVTEDCQ | 1121 | Q5VTT5 |